Meng et al. confirmed that DCH inhibited EMT progression and vimentin formation in HCC by inhibiting MMP activity [44]; some studies showed that DCH could inhibit stem cell properties and EMT in pancreatic cancer and breast cancer and progression [25, 45]. Here, VIM is linked to hepatocellular carcinoma.